Companies / Lyra Therapeutics, Inc. / Activity
Activity — Lyra Therapeutics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Exit | Common Stock | $-37.7K | -12K -100.00% | 0 | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Exit | Common Stock | $-7.4K | -2K -100.00% | 0 | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Exit | Common Stock | $-6.0K | -2K -100.00% | 0 | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common Stock | $564 | +183 +1016.67% | 201 0.01% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | Exit | Common Stock | $-430 | -48 -100.00% | 0 | low |
| Q2 2025 as of | Barclays PLC 13F manager | New | Common Stock | $430 | +48 | 48 <0.01% of shares | low |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Exit | Common Stock | $-49 | -16 -100.00% | 0 | low |
| Q4 2025 as of | IFP Advisors, Inc 13F manager | Trim | Common Stock | $-3 | -1 -50.00% | 1 <0.01% of shares | low |